New COVID variants Epsilon, Lambda may be resistant to vaccines, early lab studies show – NJ.com
The Epsilon and Lambda variants of COVID-19 are “variants of interest,” according to the Centers for Disease Control and Prevention (CDC), and early studies show they have developed a resistance to vaccines.
Japanese researchers found the Lambda variant, which was initially discovered in Peru and is now spreading throughout South America, is highly transmissible and more resistant to vaccines than the initial COVID-19 strain.
The researchers warned in a paper posted July 28 that has yet to be peer reviewed that Lambda’s label as a “variant of interest” instead of a “variant of concern” might downplay the growing threat of the strain.
Meanwhile, the Epsilon variant that was initially discovered in California in 2020 is spreading in Pakistan and is proving to be resistant to vaccines, ...